April 24, 2012

Cover Story

CEO of the Year

Utah’s business landscape is rich with professionals who have le...Read More

Featured Articles

Did you go Skiing this winter?

Around Utah


Martin Plaehn

Karen Sendelback

Legal Briefs
Social Media and Employers: Friends or Enemies?

Money Talk
The Case for HSAs

Economic Insight
Time to Show Up

Lessons Learned
Make a Move

In the Lab

Rent to Own

Business Trends
Back from the Dead

Living Well
Artful Inspiration

A Breath of Fresh Air

Worst-Case Scenario

Regional Report
Northern Utah

Measure Up

Industry Outlook
Travel & Tourism



BSD Medical Announces Study Featuring MicroThermX Microwave Ablation System

Press Release

April 24, 2012

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, announced that a scientific poster presented at the Society of Interventional Radiology (SIR) conference, featuring data generated using the MicroThermX Microwave Ablation System (MicroThermX), demonstrated a significant advantage for MicroThermX microwave ablation. The study, ‘Impact of Variation in Portal Venous Blood Flow on the Size of Radiofrequency and Microwave Ablation Lesions,’ was conducted by Gerald D. Dodd, III, MD, Nicolas A. Dodd, and Anthony C. Lanctot, MS, Department of Radiology, University of Colorado, School of Medicine. Dodd, one of the pioneers in Radiofrequency (RF) ablation, presented the data from the in-vitro study, which was designed to assess the impact of variations in blood flow on ablation zones produced using the microwave MicroThermX compared to a commercially available RF system. The presentation received an award at the SIR conference.

"Microwave ablation is able to deliver a predictable and reproducible heating pattern that is not influenced by physiological changes in blood flow in the liver," said Dodd. "This is a significant clinical advantage over RF ablation, which is significantly impacted by physiological changes in blood flow in the liver. Predictable and reproducible ablations are a critical element of treatment planning for ablation. Not knowing the size of the ablation that you are going to get when treating a liver tumor leads to both over-treatment and under-treatment. Over-treatment poses the risk of injury to adjacent vital structures, and under-treatment means you didn't 'kill' the tumor. The predictable and reproducible performance of microwave ablation should translate to improved clinical results for cancer patients."

Utah Business Social
UB Events View All
CEO of the YearUtah Business Event
Mar 20, 2015
Utah Business Magazine and Presenting Sponsors - Holland & Hart and Newmark Grubb ACRES - are pro...
Job Summit 2015Utah Business Event
Apr 10, 2015
Position your company as a Premier Employer in today's competitive job market! Utah Business maga...
30 Women to WatchUtah Business Event
May 21, 2015
Utah Business magazine and Snell and Wilmer are proud to announce the 18th annual 30 Women To Wat...
Community Events View All
Mac OS X Support Essentials
Feb 27, 2015
Using Apple Certified Curriculum, Mac OS X Support Essentials is a hands-on course that provides ...
CEH - Certified Ethical Hacker
Mar 2, 2015
Learn to hack like a pro, while pleasing the boss! The ethical hacker is usually a trusted employ...

info@utahbusiness.com  |  90 South 400 West, Ste 650 Salt Lake City, Utah 84101   |  (801) 568-0114

Advertise with Utah Business

Submit an Event

* indicates required information
* Event Name:
Price (general):
Website (if applicable):
Coordinator's Name:
Coordinator's Email:
Coordinator's Phone:
Venue Name:
Venue Address:
Venue City:
Venue Zip:
Event Capacity:
* Event Description: